Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_assertion type Assertion NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_head.
- NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_assertion description "[We conclude that miR-362-3p may be a novel prognostic marker in CRC, and hypothesize that the positive effects of augmented miR-362-3p expression may in part be mediated through the targets E2F1, USF2 and PTPN1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_provenance.
- NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_assertion evidence source_evidence_literature NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_provenance.
- NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_assertion SIO_000772 23280316 NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_provenance.
- NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_assertion wasDerivedFrom befree-20150227 NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_provenance.
- NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_assertion wasGeneratedBy ECO_0000203 NP1003550.RAeTPjbyUJHYQt6Ls9Ezu-mnDB3UwgYRIMN1occqXwMOM130_provenance.